A股異動 | 中核鈦白(002145.SZ)逼近漲停續創新高 市值超280億元
格隆匯5月13日丨中核鈦白(002145.SZ)盤中快速拉昇,股價逼近漲停。高見13.86元再創歷史新高價,該股年內已暴漲150%,總市值超280億元。中核鈦白日前宣佈,全面上調公司各型號鈦白粉銷售價格。其中:國內客户銷售價格上調1000元人民幣/噸,國際客户出口價格上調150美元/噸。自2020年三季度開始,隨着國內外需求逐步恢復,同時鈦礦成本端高壓,鈦白粉行業開啟了新一輪漲價週期。太平洋證券預計後期鈦白粉價格易漲難跌,行業高景氣度有望延續。2021年,公司計劃生產鈦白粉33.5萬噸,同比+5.5%,努力做到產銷平衡,計劃實現銷售收入超55億元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.